|
|
| | Linagliptin Impurity F Basic information |
| Product Name: | Linagliptin Impurity F | | Synonyms: | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide;Linagliptin Impurity QQ: What is
Linagliptin Impurity Q Q: What is the CAS Number of
Linagliptin Impurity Q Q: What is the storage condition of
Linagliptin Impurity Q;(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity);(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace;Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-2,2,2-trifluoro-;Linagliptin-6;(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl;Linagliptin impurity 5/(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide | | CAS: | 1673546-62-7 | | MF: | C27H27F3N8O3 | | MW: | 568.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1673546-62-7.mol |  |
| | Linagliptin Impurity F Chemical Properties |
| density | 1.46±0.1 g/cm3(Predicted) | | pka | 10.63±0.20(Predicted) |
| | Linagliptin Impurity F Usage And Synthesis |
| Uses | 3-Trifluoroacetylamino Linagliptin is a derivative of Linagliptin , which is a DPP-??4 (dipeptidyl peptidase-??4) inhibitor used in the treatment of type 2 diabetes. |
| | Linagliptin Impurity F Preparation Products And Raw materials |
|